Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines

Area of Science:

• Vaccinology
• Public Health
• Epidemiology

Background:

• Human rabies vaccines have advanced from early nerve tissue preparations to modern cell culture-derived vaccines.
• Current potent rabies vaccines reduce dose requirements but remain unaffordable for many at-risk populations.
• The cost of post-exposure prophylaxis (PEP) includes direct medical expenses and indirect patient costs like travel and lost income.

Purpose of the Study:

• To summarize the evaluation criteria used by the SAGE Working Group and WHO for recommending a new rabies post-exposure prophylaxis regimen.
• To assess the feasibility of a one-week intradermal vaccination schedule (2-2-2-0-0) for rabies PEP.

Main Methods:

• Review of criteria for recommending new rabies PEP regimens.
• Evaluation focused on cost-effectiveness, dose reduction, seroconversion rates, efficacy, safety, and patient follow-up.
• Assessment of a one-week intradermal vaccination regimen (2-2-2-0-0).

Main Results:

• The study evaluated criteria including cost-effectiveness, number of doses, seroconversion, efficacy, safety, and patient follow-up.
• The focus was on the potential of a new one-week intradermal vaccination regimen for rabies post-exposure prophylaxis.
• Criteria aimed to ensure a balance between vaccine effectiveness and patient accessibility.

Conclusions:

• The evaluation criteria support the recommendation of new, potentially more accessible rabies vaccination strategies.
• Cost-effectiveness and reduced patient burden are key considerations for widespread rabies PEP implementation.
• Optimizing rabies prophylaxis regimens is crucial for global public health efforts against the disease.